ID   EBC-2
AC   CVCL_DH99
SY   EBC2
DR   Wikidata; Q54831760
RX   PubMed=10213231;
RX   PubMed=11844606;
CC   Population: Japanese.
CC   HLA typing: A*31:12,33:03; B*35:01,44:31; C*03:03,14:03; DQB1*03:02;06:04 (PubMed=10213231).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DI00 ! EBC-2/R
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
RX   PubMed=10213231;
RA   Hiraki, Akio
RA   Kaneshige, Toshihiko
RA   Kiura, Katsuyuki
RA   Ueoka, Hiroshi
RA   Yamane, Hiromishi
RA   Tanaka, Motoyuki
RA   Harada, Mine
RT   "Loss of HLA haplotype in lung cancer cell lines: implications for
RT   immunosurveillance of altered HLA class I/II phenotypes in lung
RT   cancer.";
RL   Clin. Cancer Res. 5:933-936(1999).
//
RX   PubMed=11844606; DOI=10.1016/S0169-5002(01)00430-5;
RA   Kawai, Haruyuki
RA   Kiura, Katsuyuki
RA   Tabata, Masahiro
RA   Yoshino, Tadashi
RA   Takata, Ichiro
RA   Hiraki, Akio
RA   Chikamori, Kenichi
RA   Ueoka, Hiroshi
RA   Tanimoto, Mitsune
RA   Harada, Mine
RT   "Characterization of non-small-cell lung cancer cell lines established
RT   before and after chemotherapy.";
RL   Lung Cancer 35:305-314(2002).
//